Biofrontera AG (B8FKn)

Currency in EUR
2.930
+0.060(+2.09%)
Closed·
Earnings results expected tomorrow
B8FKn is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.8702.930
52 wk Range
2.2105.100
Key Statistics
Bid/Ask
2.90 / 2.96
Prev. Close
2.93
Open
2.87
Day's Range
2.87-2.93
52 wk Range
2.21-5.1
Volume
-
Average Volume (3m)
1.5K
1-Year Change
8.1181%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
B8FKn Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Biofrontera AG News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Earnings

Latest Release
Sep 03, 2026
EPS / Forecast
0.24 / --
Revenue / Forecast
5.32M / --
EPS Revisions
Last 90 days

B8FKn Income Statement

Compare B8FKn to Peers and Sector

Metrics to compare
B8FKn
Peers
Sector
Relationship
P/E Ratio
17.6x17.7x−0.2x
PEG Ratio
0.050.440.00
Price/Book
0.9x1.5x2.6x
Price / LTM Sales
1.1x1.3x2.7x
Upside (Analyst Target)
-26.4%68.5%
Fair Value Upside
Unlock7.8%11.5%Unlock

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. In addition, the company focus on photodynamic therapy (PDT) for the treatment of actinic keratosis and keratinocyte skin cancers, including basal cell carcinoma. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Employees
62
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
4.68M77.00%13.43M
Public Companies & Retail Investors
1.40M23.00%4.01M
Total
6.08M100.00%17.44M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Deutsche Balaton AG42.62%2,590,0327,433
DELPHI Unternehmensberatung Aktiengesellschaft19.61%1,191,7073,420

People Also Watch

347.80
MTXGn
-2.03%
39.180
NDXG
-3.02%
59.200
GBFG
-1.74%
161.35
SHBa
-0.98%

FAQ

What Is the Biofrontera AG (B8FKn) Stock Price Today?

The Biofrontera AG stock price today is 2.930 EUR.

What Stock Exchange Does Biofrontera AG Trade On?

Biofrontera AG is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Biofrontera AG?

The stock symbol for Biofrontera AG is "B8FKn."

What Is the Biofrontera AG Market Cap?

As of today, Biofrontera AG market cap is 17.810M EUR.

What Is Biofrontera AG's Earnings Per Share (TTM)?

The Biofrontera AG EPS (TTM) is 0.16.

When Is the Next Biofrontera AG Earnings Date?

Biofrontera AG will release its next earnings report on Nov 19, 2026.

From a Technical Analysis Perspective, Is B8FKn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Biofrontera AG Stock Split?

Biofrontera AG has split 6 times.

How Many Employees Does Biofrontera AG Have?

Biofrontera AG has 62 employees.

What is the current trading status of Biofrontera AG (B8FKn)?

As of Nov 18, 2026, Biofrontera AG (B8FKn) is trading at a price of 2.930 EUR, with a previous close of 2.930 EUR. The stock has fluctuated within a day range of 2.870 EUR to 2.930 EUR, while its 52-week range spans from 2.210 EUR to 5.100 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.